Login
Registrati
Reimposta password
Pubblica & Distribuisci
Soluzioni Editoriali
Soluzioni di Distribuzione
Temi
Architettura e design
Arti
Business e Economia
Chimica
Chimica industriale
Farmacia
Filosofia
Fisica
Geoscienze
Ingegneria
Interesse generale
Legge
Letteratura
Linguistica e semiotica
Matematica
Medicina
Musica
Scienze bibliotecarie e dell'informazione, studi library
Scienze dei materiali
Scienze della vita
Scienze informatiche
Scienze sociali
Sport e tempo libero
Storia
Studi classici e del Vicino Oriente antico
Studi culturali
Studi ebraici
Teologia e religione
Pubblicazioni
Riviste
Libri
Atti
Editori
Blog
Contatti
Cerca
EUR
USD
GBP
Italiano
English
Deutsch
Polski
Español
Français
Italiano
Carrello
Home
Riviste
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Numero 2 (June 2019)
Accesso libero
Atherogenic Impact of Homocysteine: Can
HMG-CoA
Reductase Inhibitors Additionally Influence Hyperhomocysteinaemia?
Tamara Nikolic
Tamara Nikolic
,
Ivan Srejovic
Ivan Srejovic
,
Isidora Stojic
Isidora Stojic
,
Jovana Jeremic
Jovana Jeremic
,
Marko Folic
Marko Folic
,
Stevan Matic
Stevan Matic
,
Milena Rakocevic
Milena Rakocevic
,
Snezana Jancic
Snezana Jancic
,
Biljana Jakovljevic
Biljana Jakovljevic
,
Radmila Obrenovic
Radmila Obrenovic
,
Dusan Djuric
Dusan Djuric
e
Vladimir Zivkovic
Vladimir Zivkovic
| 30 lug 2019
Experimental and Applied Biomedical Research (EABR)
Volume 20 (2019): Numero 2 (June 2019)
INFORMAZIONI SU QUESTO ARTICOLO
Articolo precedente
Articolo Successivo
Sommario
Bibliografia
Autori
Articoli in questo Numero
Anteprima
PDF
Cita
CONDIVIDI
Pubblicato online:
30 lug 2019
Pagine:
37 - 46
Ricevuto:
17 ott 2017
Accettato:
23 ott 2017
DOI:
https://doi.org/10.1515/sjecr-2017-0055
Parole chiave
atherogenic index
,
hyperhomocysteinaemia
,
liver
,
HMG-CoA reductase inhibitors
© 2019 Tamara Nikolic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Tamara Nikolic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Ivan Srejovic
Department of Physiology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Isidora Stojic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Jovana Jeremic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Marko Folic
Department of Pharmacy, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Stevan Matic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Milena Rakocevic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Snezana Jancic
Department of Pathology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia
Biljana Jakovljevic
Medical College of Applied Sciences
Belgrade, Serbia
Radmila Obrenovic
Institute for Medical Biochemistry Clinical Centre of Serbia
Belgrade, Serbia
Dusan Djuric
Faculty of Medicine, Institute of Medical Physiology “Richard Burian” University of Belgrade
Belgrade, Serbia
Vladimir Zivkovic
Department of Physiology, University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia